Greenspring Advisors’s Quest Diagnostics DGX Stock Holding History

Greenspring Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$479K	Buy	2,445 +3	+0.1%	+$583	0.03%	181
2025 Q4	$424K	Buy	2,442 +524	+27%	+$95.4K	0.03%	185
2025 Q3	$366K	Buy	+1,918	New	+$340K	0.06%	74
2025 Q1	$325K	Hold	1,918	–	–	0.08%	70
2024 Q4	$289K	Hold	1,918	–	–	0.06%	68
2024 Q3	$298K	Hold	1,918	–	–	0.07%	71
2024 Q2	$263K	Hold	1,918	–	–	0.06%	57
2024 Q1	$255K	Hold	1,918	–	–	0.06%	61
2023 Q4	$264K	Hold	1,918	–	–	0.07%	54
2023 Q3	$234K	Hold	1,918	–	–	0.07%	55
2023 Q2	$270K	Sell	1,918 -1,354	-41%	-$187K	0.08%	46
2023 Q1	$463K	Hold	3,272	–	–	0.1%	69
2022 Q4	$512K	Buy	3,272 +1,354	+71%	+$195K	0.14%	64
2022 Q3	$235K	Hold	1,918	–	–	0.07%	94
2022 Q2	$255K	Hold	1,918	–	–	0.08%	92
2022 Q1	$263K	Hold	1,918	–	–	0.07%	86
2021 Q4	$332K	Buy	+1,918	New	+$292K	0.09%	79

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Greenspring Advisors's DGX Position: Q1 2026 in Review

Greenspring Advisors increased its Quest Diagnostics (DGX) stake by 0.12% in Q1 2026, buying an estimated $583 and bringing the position to 2,445 shares worth $479K. The position accounts for 0.03% of the portfolio, ranked #181.

Greenspring Advisors first reported a position in DGX in Q4 2021 and has held it in 17 quarters since. The position peaked at $512K in Q4 2022. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Greenspring Advisors held 2,445 shares of Quest Diagnostics worth $479K as of Q1 2026.
Greenspring Advisors bought 3 Quest Diagnostics shares in Q1 2026, an estimated $583.
Quest Diagnostics made up 0.03% of Greenspring Advisors's portfolio in Q1 2026, its #181 holding.
Greenspring Advisors first reported a position in Quest Diagnostics in Q4 2021 and has held it in 17 quarters since.
Greenspring Advisors's Quest Diagnostics position peaked at $512K in Q4 2022.
1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Greenspring Advisors's 13F filing for Q1 2026, filed 5 May 2026.